Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The crystal structure of human CD1b with a bound bacterial glycolipid.

Batuwangala T, Shepherd D, Gadola SD, Gibson KJ, Zaccai NR, Fersht AR, Besra GS, Cerundolo V, Jones EY.

J Immunol. 2004 Feb 15;172(4):2382-8.

2.

The molecular basis of CD1-mediated presentation of lipid antigens.

Moody DB, Besra GS, Wilson IA, Porcelli SA.

Immunol Rev. 1999 Dec;172:285-96. Review.

PMID:
10631954
3.

Immunity to glycolipid antigens in microbial infections.

De Libero G, Donda A, Mori L, Manolova V, Shamshiev A.

J Biol Regul Homeost Agents. 2001 Jul-Sep;15(3):249-56. Review.

PMID:
11693433
4.

CD1-mediated immune responses to glycolipids.

Burdin N, Kronenberg M.

Curr Opin Immunol. 1999 Jun;11(3):326-31. Review.

PMID:
10375559
5.

Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells.

Gadola SD, Karadimitris A, Zaccai NR, Salio M, Dulphy N, Shepherd D, Jones EY, Cerundolo V.

Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):875-7. Review.

6.

Anatomy of CD1-lipid antigen complexes.

Moody DB, Zajonc DM, Wilson IA.

Nat Rev Immunol. 2005 May;5(5):387-99. Review.

PMID:
15864273
7.

CD1 mediated T cell recognition of glycolipids.

Zajonc DM, Kronenberg M.

Curr Opin Struct Biol. 2007 Oct;17(5):521-9. Epub 2007 Oct 24. Review.

8.

The surprising diversity of lipid antigens for CD1-restricted T cells.

Moody DB.

Adv Immunol. 2006;89:87-139. Review.

PMID:
16682273
9.

The Third Way: Progress on pathways of antigen processing and presentation by CD1.

Lawton AP, Kronenberg M.

Immunol Cell Biol. 2004 Jun;82(3):295-306. Review.

10.

[CD1 pathway and NK T cell activation to glycolipid antigens from Mycobacterium tuberculosis].

Sada-Ovalle I, Torre-Bouscoulet L, Jiménez-Martínez Mdel C, Martínez-Cairo S, Zenteno E, Lascurain R.

Gac Med Mex. 2005 Jan-Feb;141(1):35-41. Review. Spanish.

PMID:
15754749
11.

CD1d-mediated antigen presentation to natural killer T (NKT) cells.

Brutkiewicz RR, Lin Y, Cho S, Hwang YK, Sriram V, Roberts TJ.

Crit Rev Immunol. 2003;23(5-6):403-19. Review.

PMID:
15030309
12.

CD1 assembly and the formation of CD1-antigen complexes.

Hava DL, Brigl M, van den Elzen P, Zajonc DM, Wilson IA, Brenner MB.

Curr Opin Immunol. 2005 Feb;17(1):88-94. Review.

PMID:
15653316
13.

New insights into pathways for CD1-mediated antigen presentation.

Sugita M, Cernadas M, Brenner MB.

Curr Opin Immunol. 2004 Feb;16(1):90-5. Review.

PMID:
14734115
14.

T-cell recognition of glycolipids presented by CD1 proteins.

Young DC, Moody DB.

Glycobiology. 2006 Jul;16(7):103R-112R. Epub 2006 Apr 5. Review.

PMID:
16597658
15.

The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.

Godfrey DI, Rossjohn J, McCluskey J.

Immunity. 2008 Mar;28(3):304-14. doi: 10.1016/j.immuni.2008.02.004. Review.

16.

Glycolipids as immune modulatory tools.

Lalazar G, Preston S, Zigmond E, Ben Yáacov A, Ilan Y.

Mini Rev Med Chem. 2006 Nov;6(11):1249-53. Review.

PMID:
17100636
17.

CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.

Florence WC, Bhat RK, Joyce S.

Expert Rev Mol Med. 2008 Jul 7;10:e20. doi: 10.1017/S1462399408000732. Review.

PMID:
18601810
18.

CD1d ligands: the good, the bad, and the ugly.

Brutkiewicz RR.

J Immunol. 2006 Jul 15;177(2):769-75. Review.

19.

Sheep CD1 genes and proteins.

Hopkins J, Dutia BM, Rhind SM.

Vet Immunol Immunopathol. 2000 Jan 31;73(1):3-14. Review.

PMID:
10678394
20.

Lipid metabolism, atherogenesis and CD1-restricted antigen presentation.

Major AS, Joyce S, Van Kaer L.

Trends Mol Med. 2006 Jun;12(6):270-8. Epub 2006 May 2. Review.

PMID:
16651026

Supplemental Content

Support Center